Carlos Felipe will have to wait to make his UFC debut. A significant amount of time.
The Brazilian heavyweight was suspended two years by USADA, the UFC's anti-doping partner, for testing positive for the steroid stanozolol, the agency announced Friday. Felipe, 22, failed a drug test, stemming from a July 29 out-of-competition sample collection, for the metabolites 16β‐hydroxy‐stanozolol and 3’‐hydroxy‐stanozolol.
Stanozolol is under the anabolic agents category of the UFC’s anti-doping policy, is prohibited at all times and carries a two-year maximum suspension.
Felipe (8-0) was removed from a fight with Christian Colombo at UFC Sao Paulo on Oct. 28 last month when the results from his drug test came back. His two-year period of UFC ineligibility began Sept. 19, so he will be able to compete in the Octagon in September 2019.
The heavyweight prospect has finished six of his eight victories by knockout.